11/15/2025
π£ Your response is needed! Our newest survey is live.
In designing a clinical trial, it is important to develop and capture outcomes of specific endpoints (goals) to establish whether or not a new therapy is beneficial to and/or desired by a person living with sickle cell disease (SCD).
Pain has been a traditional endpoint used to make that determination. However, we understand there are other SCD complications that should be taken into consideration as endpoints, such as sleep deprivation or fatigue. This survey will help SCDAA guide the development of research protocols that more accurately reflect the needs of the sickle cell community. Share your thoughts: https://bit.ly/4i6NFHa